Levels of luteinizing hormone (LH), follicle-stimulating hormone, and 17β-estradiol in response to D-Trp6-LH-releasing hormone during different phases of the menstrual cycle in normal women

C. J. Jaramillo, A. C. Salgado, V. Perez-Infante, M. Puente-Cueva, J. Botella-Llusia, D. H. Coy, Andrew V Schally

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The response of luteinizing hormone (LH), follicle-stimulating hormone (FSH), and 17β-estradiol to D-Trp6-LH-releasing hormone (LH-RH) was studied in 34 normal women. This long-acting, superactive analog was given by several routes of administration (intravenously, intramuscularly, and by continuous intravenous infusion) and in increasing doses of 1 to 50 μg in three phases of the menstrual cycle: late follicular (8th to 10th days of the cycle) preovulatory (11th to 13th days if the cycle), and ovulatory (14th day of the cycle). In all phases of the cycle, LH and FSH responses to the analog increased significantly (P<0.05) from 60 minutes as compared with basal levels, with a duration of at least 8 hours. After the intravenous administration of 10 μg of D-Trp6-LH-RH, 17β-estradiol reached a statistically significant value (P<0.05) at 8 hours. During the follicular phase, D-Trp6-LH-RH was 40 and 21 times more potent than LH-RH in stimulating the release of LH and FSH, respectively. When 10 μg of the analog was administered by continuous intravenous infusion, the kinetics of the LH and FSH response in the ovulatory phase were different from responses in the follicular and preovulatory phases, with a faster release of gonadotropins at 2 hours in comparison with that in the other phases. In addition, the total amounts of LH and FSH released were twice as great in the ovulatory phase as in the two other phases. The release of LH and FSH in women was nearly always statistically greater (P<0.05) in comparison with that observed in men. The high potency and prolonged duration of action of this compound suggest its potential usefulness for increasing estradiol levels and for stimulation of ovulation in women.

Original languageEnglish
Pages (from-to)153-158
Number of pages6
JournalFertility and Sterility
Volume29
Issue number2
StatePublished - Dec 1 1978
Externally publishedYes

Fingerprint

Follicle Stimulating Hormone
Menstrual Cycle
Luteinizing Hormone
Gonadotropin-Releasing Hormone
Estradiol
Follicular Phase
Intravenous Infusions
Ovulation
Gonadotropins
Intravenous Administration

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Levels of luteinizing hormone (LH), follicle-stimulating hormone, and 17β-estradiol in response to D-Trp6-LH-releasing hormone during different phases of the menstrual cycle in normal women. / Jaramillo, C. J.; Salgado, A. C.; Perez-Infante, V.; Puente-Cueva, M.; Botella-Llusia, J.; Coy, D. H.; Schally, Andrew V.

In: Fertility and Sterility, Vol. 29, No. 2, 01.12.1978, p. 153-158.

Research output: Contribution to journalArticle

@article{f5e2ef84de794b919375243355d953b1,
title = "Levels of luteinizing hormone (LH), follicle-stimulating hormone, and 17β-estradiol in response to D-Trp6-LH-releasing hormone during different phases of the menstrual cycle in normal women",
abstract = "The response of luteinizing hormone (LH), follicle-stimulating hormone (FSH), and 17β-estradiol to D-Trp6-LH-releasing hormone (LH-RH) was studied in 34 normal women. This long-acting, superactive analog was given by several routes of administration (intravenously, intramuscularly, and by continuous intravenous infusion) and in increasing doses of 1 to 50 μg in three phases of the menstrual cycle: late follicular (8th to 10th days of the cycle) preovulatory (11th to 13th days if the cycle), and ovulatory (14th day of the cycle). In all phases of the cycle, LH and FSH responses to the analog increased significantly (P<0.05) from 60 minutes as compared with basal levels, with a duration of at least 8 hours. After the intravenous administration of 10 μg of D-Trp6-LH-RH, 17β-estradiol reached a statistically significant value (P<0.05) at 8 hours. During the follicular phase, D-Trp6-LH-RH was 40 and 21 times more potent than LH-RH in stimulating the release of LH and FSH, respectively. When 10 μg of the analog was administered by continuous intravenous infusion, the kinetics of the LH and FSH response in the ovulatory phase were different from responses in the follicular and preovulatory phases, with a faster release of gonadotropins at 2 hours in comparison with that in the other phases. In addition, the total amounts of LH and FSH released were twice as great in the ovulatory phase as in the two other phases. The release of LH and FSH in women was nearly always statistically greater (P<0.05) in comparison with that observed in men. The high potency and prolonged duration of action of this compound suggest its potential usefulness for increasing estradiol levels and for stimulation of ovulation in women.",
author = "Jaramillo, {C. J.} and Salgado, {A. C.} and V. Perez-Infante and M. Puente-Cueva and J. Botella-Llusia and Coy, {D. H.} and Schally, {Andrew V}",
year = "1978",
month = "12",
day = "1",
language = "English",
volume = "29",
pages = "153--158",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Levels of luteinizing hormone (LH), follicle-stimulating hormone, and 17β-estradiol in response to D-Trp6-LH-releasing hormone during different phases of the menstrual cycle in normal women

AU - Jaramillo, C. J.

AU - Salgado, A. C.

AU - Perez-Infante, V.

AU - Puente-Cueva, M.

AU - Botella-Llusia, J.

AU - Coy, D. H.

AU - Schally, Andrew V

PY - 1978/12/1

Y1 - 1978/12/1

N2 - The response of luteinizing hormone (LH), follicle-stimulating hormone (FSH), and 17β-estradiol to D-Trp6-LH-releasing hormone (LH-RH) was studied in 34 normal women. This long-acting, superactive analog was given by several routes of administration (intravenously, intramuscularly, and by continuous intravenous infusion) and in increasing doses of 1 to 50 μg in three phases of the menstrual cycle: late follicular (8th to 10th days of the cycle) preovulatory (11th to 13th days if the cycle), and ovulatory (14th day of the cycle). In all phases of the cycle, LH and FSH responses to the analog increased significantly (P<0.05) from 60 minutes as compared with basal levels, with a duration of at least 8 hours. After the intravenous administration of 10 μg of D-Trp6-LH-RH, 17β-estradiol reached a statistically significant value (P<0.05) at 8 hours. During the follicular phase, D-Trp6-LH-RH was 40 and 21 times more potent than LH-RH in stimulating the release of LH and FSH, respectively. When 10 μg of the analog was administered by continuous intravenous infusion, the kinetics of the LH and FSH response in the ovulatory phase were different from responses in the follicular and preovulatory phases, with a faster release of gonadotropins at 2 hours in comparison with that in the other phases. In addition, the total amounts of LH and FSH released were twice as great in the ovulatory phase as in the two other phases. The release of LH and FSH in women was nearly always statistically greater (P<0.05) in comparison with that observed in men. The high potency and prolonged duration of action of this compound suggest its potential usefulness for increasing estradiol levels and for stimulation of ovulation in women.

AB - The response of luteinizing hormone (LH), follicle-stimulating hormone (FSH), and 17β-estradiol to D-Trp6-LH-releasing hormone (LH-RH) was studied in 34 normal women. This long-acting, superactive analog was given by several routes of administration (intravenously, intramuscularly, and by continuous intravenous infusion) and in increasing doses of 1 to 50 μg in three phases of the menstrual cycle: late follicular (8th to 10th days of the cycle) preovulatory (11th to 13th days if the cycle), and ovulatory (14th day of the cycle). In all phases of the cycle, LH and FSH responses to the analog increased significantly (P<0.05) from 60 minutes as compared with basal levels, with a duration of at least 8 hours. After the intravenous administration of 10 μg of D-Trp6-LH-RH, 17β-estradiol reached a statistically significant value (P<0.05) at 8 hours. During the follicular phase, D-Trp6-LH-RH was 40 and 21 times more potent than LH-RH in stimulating the release of LH and FSH, respectively. When 10 μg of the analog was administered by continuous intravenous infusion, the kinetics of the LH and FSH response in the ovulatory phase were different from responses in the follicular and preovulatory phases, with a faster release of gonadotropins at 2 hours in comparison with that in the other phases. In addition, the total amounts of LH and FSH released were twice as great in the ovulatory phase as in the two other phases. The release of LH and FSH in women was nearly always statistically greater (P<0.05) in comparison with that observed in men. The high potency and prolonged duration of action of this compound suggest its potential usefulness for increasing estradiol levels and for stimulation of ovulation in women.

UR - http://www.scopus.com/inward/record.url?scp=0018090568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018090568&partnerID=8YFLogxK

M3 - Article

VL - 29

SP - 153

EP - 158

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 2

ER -